Lappe Mark

Chief Executive Officer, DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Sep 8, 2026
Net Buying
Open-Market Buys
$2.6M
Open-Market Sells
$0
Net Open-Market Flow
$2.6M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 8, 2026Buy(P)6K$99.29$585K711K
Sep 8, 2026Buy(P)7K$100.64$665K718K
Sep 8, 2026Buy(P)1K$107.12$118K719K
Sep 8, 2026Buy(P)500$108.23$54K720K
Sep 8, 2026Buy(P)1K$111.88$136K721K
Sep 8, 2026Buy(P)10K$112.28$1.1M731K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001366074-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about INBX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001366074-26-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at Inhibrx Biosciences, Inc.
over the last 90 days and cite the filings.